Investing in the Future of Health: OIF Supports Breakthroughs in Immunity Enhancement
At Oman Investment fund (OIF), we invest across a broad spectrum of economic sectors — but every investment decision is guided by a unifying principle: we choose companies, industries, and technologies that demonstrate the potential to endure and enhance the quality of life for future generations. Each investment opportunity is carefully assessed by our expert team for long-term value, sustainability, and impact.
We are excited to announce a new addition to our investment portfolio: a promising and innovative start-up in the field of Bionomic Medicine, focused on advancing human immune system enhancement.
Doris Benson, OIF’s healthcare technologies expert, explains the importance of this area of research:
“Scientific research identifies two primary types of immunity: humoral and cell-mediated. While humoral immunity (antibody-mediated) is effective against bacterial infections, long-term protection from viral diseases often depends on cell-mediated immunity. This explains why many people contract illnesses like chickenpox only once in their lifetime.
However, for many viral diseases — including some of the most dangerous — the development of lifelong immunity through preventive treatments remains an unsolved challenge. Bionomic Medicine is at the frontier of addressing this. At OIF, we believe that supporting this research is crucial for the advancement of public health, and we are confident our investment will contribute meaningfully to these efforts.”
Ryan Smith, Head of the Innovative Investments Department at OIF, adds:
“This initiative is part of our broader commitment to support high-impact research across a variety of emerging fields. The global focus on immune resilience, especially in light of recent events, has made it clear that innovation in healthcare is not just important — it’s imperative.
By investing in Bionomic Medicine, we’re aligning ourselves with a technology that not only holds promise for improving global health but also offers strong long-term investment potential.”
Our global research and investment teams continuously analyze markets around the world, seeking out next-generation companies with innovative solutions that align with our vision of sustainable and forward-looking growth.
